Shares in Chembio Diagnostics (CEMI) spiked 8% on Thursday after the company announced that its DPP Covid-19 point-of-care test has been selected for use by Stony Brook Medicine to recruit coronavirus survivors.Stony Brook is carrying out a study to determine if convalescent blood plasma, the plasma from people who have recovered from Covid-19, can help treat hospitalized patients with active Covid-19 infection.The Chembio test is being used to confirm that patients were infected with Covid-19 and now have adequate levels of IgG antibodies to make them eligible to donate convalescent plasma.The company’s patented DPP technology platform, which uses a small drop of blood from the fingertip, provides high-quality, cost-effective results in approximately 15 minutes.“We are pleased that our unique and proprietary DPP technology, which can separately and simultaneously detect and measure IgM and IgG antibodies specific to COVID-19, is the assay of choice for Stony Brook Medicine,” stated Javan Esfandiari, Executive VP...
(Bloomberg) -- The U.S. will have a large number of tests available within about a week, according to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.Spain reported the fewest number of deaths since March 24, and the pace of new cases slowed in Germany. Italy is seeing a downward trend in infections and may extend its lockdown, while U.K. Prime Minister Boris Johnson left intensive care and is starting to recover.U.S. Vice President Mike Pence and one of the country’s top health officials said reopening the economy hinges partly on the government seeing major communities at the end of their outbreaks. Key DevelopmentsCoronavirus Tracker: Global Cases 1.62 Million; Deaths 97,000‘No Sail Order’ for cruise ships extended; Boeing may cut jobsPotential coronavirus drugs may cost as little as $1, study saysHong Kong edge over Singapore shows early social distance worksAmerica worships from the parking lot, online to avoid...
Have you read Ayn Rand’s novel Atlas Shrugged? The main theme of the book is that – overwhelmed by growing statism – entrepreneurs at one point say finally “basta!” and announce a strike....
